Mizuho MedyLtd Full Year 2024 Earnings: EPS: JP¥198 (vs JP¥396 in FY 2023)

Mizuho MedyLtd (TSE:4595) Full Year 2024 Results

Key Financial Results

• Revenue: JP¥11.4b (up 4.0% from FY 2023).
• Net income: JP¥3.77b (flat on FY 2023).
• Profit margin: 33% (down from 34% in FY 2023). The decrease in margin was driven by higher expenses.
• EPS: JP¥198 (down from JP¥396 in FY 2023).

All figures shown in the chart above are for the trailing 12 month (TTM) period

Mizuho MedyLtd Earnings Insights

Looking ahead, revenue is expected to decline by 2.9% p.a. on average during the next 2 years, while revenues in the Medical Equipment industry in Japan are expected to grow by 6.9%.

Performance of the Japanese Medical Equipment industry.

The company's shares are down 4.4% from a week ago.

Risk Analysis

You should learn about the 1 warning sign we've spotted with Mizuho MedyLtd.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.